CATALOGO DEI PRODOTTI DELLA RICERCA

CALABRESE, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.712
EU - Europa 2.424
AS - Asia 1.036
OC - Oceania 11
SA - Sud America 6
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.702
CN - Cina 772
GB - Regno Unito 553
IT - Italia 443
SE - Svezia 305
FR - Francia 252
IE - Irlanda 252
RU - Federazione Russa 225
DE - Germania 137
FI - Finlandia 114
SG - Singapore 110
VN - Vietnam 69
UA - Ucraina 48
KR - Corea 23
BE - Belgio 20
HK - Hong Kong 19
NL - Olanda 15
MK - Macedonia 11
AU - Australia 9
JP - Giappone 9
AT - Austria 8
CA - Canada 8
TR - Turchia 8
ES - Italia 5
PH - Filippine 5
CH - Svizzera 4
HR - Croazia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
IL - Israele 3
IN - India 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
CY - Cipro 2
EG - Egitto 2
HU - Ungheria 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BR - Brasile 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 6.196
Salva come PNG Salva come JPEG
Città #
Chandler 682
Southend 490
Ashburn 259
Dublin 248
Beijing 192
Verona 174
Jacksonville 164
Woodbridge 151
Ann Arbor 133
Princeton 100
Redmond 97
Lawrence 93
Wilmington 78
Houston 74
Jinan 70
Helsinki 63
Singapore 63
New York 62
Dong Ket 52
Lancaster 45
Nanjing 45
Shenyang 44
Sindelfingen 44
Hebei 39
Redwood City 32
Tianjin 31
Washington 31
Seattle 28
Changsha 25
Haikou 25
Ningbo 24
Zhengzhou 24
Seoul 23
Taizhou 22
Brussels 20
Milan 20
Nanchang 19
Guangzhou 18
Norwalk 17
Hong Kong 15
Boardman 14
Hangzhou 14
Lappeenranta 14
Dongguan 13
Sant'Ambrogio di Valpolicella 13
Fuzhou 12
Rome 11
Skopje 11
Bologna 10
Fairfield 10
Taiyuan 10
Jiaxing 9
Bonndorf 8
Chicago 8
Lanzhou 8
Los Angeles 8
Padova 8
Clearwater 7
Falls Church 7
Kent 7
Riva Del Garda 7
Roverbella 7
Vienna 7
Amsterdam 6
Cambridge 6
Naples 6
San Diego 6
Chions 5
Dearborn 5
Duncan 5
Düsseldorf 5
Iloilo City 5
Paris 5
Boydton 4
London 4
Pordenone 4
Xiangfen 4
Zurich 4
Canberra 3
Chisinau 3
Giv‘atayim 3
Kemerovo 3
Olgiate Olona 3
Parma 3
Riva 3
Saint-Laurent-du-Var 3
Santa Clara 3
Sofia 3
Tokyo 3
Toronto 3
Trento 3
Valbonne 3
Vientiane 3
Albiate 2
Atlanta 2
Auckland 2
Beyoğlu 2
Biassono 2
Buenos Aires 2
Des Moines 2
Totale 4.192
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 135
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 113
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 104
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 101
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 100
A case of epilepsy in multiple sclerosis: Three-dimensional double inversion recovery sequences revealed cortical dysplasia 95
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 94
A case of acute fulminant multiple sclerosis treated with alemtuzumab 93
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 92
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 91
Assessing response to interferon-β in a multicenter dataset of patients with MS 90
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 89
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 88
Response to Nagai et al. 86
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 84
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 84
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 82
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 82
Epilepsy in multiple sclerosis: The role of temporal lobe damage 80
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 78
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 78
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 77
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 77
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 75
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 75
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 74
Can DTI and 3D-SHORE based indices differentiate RRMS from PMS Patients? 74
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 74
The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis 74
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 72
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 71
Exploring the origins of grey matter damage in multiple sclerosis. 71
Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results 69
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: yes. 68
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 67
Multiple sclerosis and epilepsy: much more than a coincidence 66
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 65
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 65
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 64
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 64
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 63
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 63
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 62
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 62
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 62
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 60
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 60
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 59
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 59
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 58
Lost in classification: lower cognitive functioning in apparently cognitive normal newly diagnosed RRMS patients 58
Explainable 3D-CNN for multiple sclerosis patients stratication 58
Interpretable Deep Learning as a means for decrypting disease signature in Multiple Sclerosis 58
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 57
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 56
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 56
Visual-attentional load unveils slowed processing speed in multiple sclerosis patients: a pilot study with a tablet-based videogame 54
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 54
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 53
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 52
Correlating Dti and 3d-Shore Based Indices with Neurological Disability Scores of Multiple Sclerosis Patients 51
A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients 50
Cortical gray matter MR imaging in multiple sclerosis 49
Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria 49
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 49
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 49
Multivariate data analysis suggests the link between brain microstructure and cognitive impairment in multiple sclerosis 48
A videogame-based approach to measuring information processing speed in multiple sclerosis patients 48
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 48
Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment 47
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 46
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 46
Informing MS patients on treatment options: a consensus on the process of consent taking 45
Social cognition in multiple sclerosis: a 3-year follow-up {MRI} and behavioral study 45
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 44
Coping strategies and their impact on quality of life and physical disability of people with multiple sclerosis 44
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis 43
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 42
False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm 42
The BAFF / APRIL system as therapeutic target in multiple sclerosis 42
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 42
Evaluation of the central vein sign as a diagnostic imaging biomarker in Multiple Sclerosis 40
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 40
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 39
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 39
"What is hidden behind the mask?" Facial emotion recognition at the time of COVID-19 pandemic in cognitively normal multiple sclerosis patients 38
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 37
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis 37
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 35
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 33
Explainable deep learning for decrypting disease signatures in multiple sclerosis 33
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 32
Imaging and depression in multiple sclerosis: a historical perspective 32
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 31
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 31
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 28
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 28
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 26
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 25
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 23
Totale 6.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.840
article - articoli 25.203
book - libri 0
conference - conferenze 2.471
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 166
Totale 55.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020449 0 21 6 12 103 48 74 6 10 52 60 57
2020/2021755 75 107 44 77 95 75 32 20 49 34 68 79
2021/2022870 48 263 5 125 18 19 34 53 27 30 64 184
2022/20231.895 116 244 158 337 129 415 45 114 220 22 53 42
2023/20241.235 38 88 105 132 124 238 102 77 17 94 154 66
2024/2025223 140 83 0 0 0 0 0 0 0 0 0 0
Totale 6.420